Research use only.  Educational reference. Not medical advice. Not for human consumption.
🌞 α-MSH Analog (Multi-Receptor)

Melanotan II (10 mg Vial) Dosage Protocol

Melanotan II is a non-selective α-MSH analog activating MC1R, MC3R, MC4R, and MC5R. Effects include pigmentation, appetite suppression, and libido increase.

⚡ Quickstart Highlights

Vial contents
10 mg Melanotan II
Final volume
3 mL
Concentration
3.33 mg/mL
One U-100 unit
33.33 mcg in 0.01 mL

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Titration (3 mL = 3.33 mg/mL)

Week / PhaseDaily DoseUnits (per injection) (mL)
Week 1250 mcg (0.25 mg)7.5 units (0.075 mL)
Week 2500 mcg (0.5 mg)15 units (0.15 mL)
Week 3750 mcg (0.75 mg)22.5 units (0.225 mL)
Weeks 4–81000 mcg (1 mg)30 units (0.30 mL)
Maintenance (after Week 8)500–1000 mcg (1–2× weekly)15–30 units (0.15–0.30 mL)

Frequency: Inject once daily subcutaneously during the initial 8-week tanning phase; transition to 1–2 injections per week for maintenance dosing to sustain pigmentation. This schedule uses the standard 3.0 mL dilution for consistent unit measurements. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to avoid foaming; do not shake vigorously.
  3. Gently roll or swirl the vial until the powder is fully dissolved.
  4. Label the vial with the reconstitution date and store refrigerated at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. Melanotan II is not an approved medication. For research use only.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration (including transition to maintenance dosing).

ItemQuantity
Peptide Vials (Melanotan II, 10 mg each)8 weeks ≈ 5 vials (~45–50 mg total)
12 weeks ≈ 8 vials (~70–75 mg total)
16 weeks ≈ 10 vials (~95–100 mg total)
Insulin Syringes (U-100, 1 mL)Per week (daily dosing): 7 syringes
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles)8 weeks (5 vials): 15 mL → 2 × 10 mL bottles
12 weeks (8 vials): 24 mL → 3 × 10 mL bottles
16 weeks (10 vials): 30 mL → 3 × 10 mL bottles
Alcohol SwabsPer week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Melanotan II is non-selective across all melanocortin receptors — producing pigmentation, appetite suppression, and libido increase together.

Storage Instructions

StateTemperatureDuration
Lyophilized−20°C (−4°F)Up to 24 months, dry & dark
Reconstituted2–8°C (35–46°F)Up to 14 days, protect from light

Important Notes

⚠ Research Use Only: Melanotan II is investigational. Mole monitoring and priapism risk awareness required.

How This Works

Melanotan II is a cyclic heptapeptide α-MSH analog with broad melanocortin receptor activity. It produces pigmentation (MC1R), appetite suppression and energy expenditure increase (MC3R/MC4R), and sexual arousal effects (MC4R).

Potential Benefits & Side Effects

Potential Benefits

Side Effect Profile

Lifestyle Factors

Injection Technique

References

1
Hadley ME, Dorr RT. 'Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization' — Peptides, 2006 View source ↗